Sphenopalatine Ganglion Block: A Promising Migraine Relief

Research Summary

A recent study published in Neurologia Neurochirurgia Polska explores the potential of sphenopalatine ganglion blockade as a treatment for episodic migraine, a condition marked by severe headaches and reduced quality of life. The study involved 31 patients, predominantly women, aged 22-55. Using a needleless applicator with 4% lidocaine, researchers performed the block twice, six weeks apart. Evaluations were conducted using the visual analogue scale (VAS), migraine disability assessment scale (MIDAS), and headache impact test-6 (HIT-6). Results showed significant pain reduction and improved daily functioning, suggesting this procedure could be a viable alternative or complement to traditional migraine medications.

Study Details

📄 Title: Assessment of the effectiveness of sphenopalatine ganglion blockade in the treatment of migraine.

👥 Research Team: Kierońska-Siwak S et al.

📚 Published In: Neurol Neurochir Pol

📅 Publication Date: 2025 Nov 20

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.